On the basis of these findings, we measured CD8+ T cell abundance in tumour tissues and found that the intra-tumour infiltration of CD8+ T lymphocytes in the combined vaccine group was significantly increased (Fig. 5). This evidence concerns the gene CD8A and neoplasm.